Background: The metabolic global approach is a multidisciplinary intervention for obese women before undergoing assisted reproductive techniques, with the goal of improving fertility and decreasing adverse pregnancy outcomes. The objective of this study was to evaluate the impact of the metabolic global approach on pregnancy rate.
Methods: This retrospective cohort study included 127 women and was conducted at the Centre hospitalier de l'Université de Montréal fertility center. Eligibility included BMI at initial consultation of ≥30 kg/m 2. Fertility treatments were considered when a weight loss of minimum 5% and normal metabolic indices were achieved. The p<0.05 was considered statistically significant.
Results: Median baseline and last clinical assessment BMIs were 38.2 kg/m 2 and 35.8 kg/m 2 respectively (p<0.001), representing a median weight loss of 5.1%. At baseline, at least one metabolic parameter was abnormal in 66% of women. Total pregnancy rate was 53%. The majority of women (63%) who achieved pregnancy did so with weight loss and metabolic stabilization alone (11%) or combined with metformin (36%) and/or oral ovulation drugs (16%). Normal vitamin D (p<0.001) and triglyceride levels (p<0.05) as well as lower BMI after weight loss (p<0.05) were associated with an increased relative risk of pregnancy.
Conclusion: Replete vitamin D status, weight loss of 5% and lower BMI as well as normal triglyceride level are significant and independent predictors of pregnancy in obese women presenting to our fertility center. The metabolic global approach is an effective program to detect metabolic abnormalities and improve obese women's pregnancy rate.
Keywords: Assisted reproductive techniques; Infertility; Metabolic syndrome; Obesity; Vitamin D deficiency.
Copyright© 2020, Avicenna Research Institute.
Conflict of interest statement
Conflict of Interest There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.Hum Reprod Update. 2016 Nov;22(6):687-708. doi: 10.1093/humupd/dmw025. Epub 2016 Aug 10. Hum Reprod Update. 2016. PMID: 27511809 Review.
Weight loss improves reproductive outcomes in obese women undergoing fertility treatment: a randomized controlled trial.Clin Obes. 2014 Apr;4(2):61-8. doi: 10.1111/cob.12048. Epub 2014 Feb 28. Clin Obes. 2014. PMID: 25826729 Clinical Trial.
Vitamin D and assisted reproductive treatment outcome: a prospective cohort study.Reprod Health. 2019 Jul 15;16(1):106. doi: 10.1186/s12978-019-0769-7. Reprod Health. 2019. PMID: 31307482 Free PMC article.
Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.J Clin Endocrinol Metab. 2015 Nov;100(11):4048-58. doi: 10.1210/jc.2015-2778. Epub 2015 Sep 24. J Clin Endocrinol Metab. 2015. PMID: 26401593 Free PMC article. Clinical Trial.
Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod Update. 2013 Jan-Feb;19(1):2-11. doi: 10.1093/humupd/dms036. Epub 2012 Sep 6. Hum Reprod Update. 2013. PMID: 22956412 Review.
- Body mass index overweight or obese, self-reported, adult, by age group and sex [Internet]. Canada: Statistics Canada; c2014–2017. Proportion of Over-weight and Obese Women in Reproductive Age, Table 13-10-0096-20 (number of persons: 1,854, 600); 2017 Nov 30 [cited December 21, 2017]; [about 1 screen]. Available from: http://www.statcan.gc.ca/tables-tableaux/sumsom/l01/cst01/health81a-eng.htm.
- Bellver J, Ayllón Y, Ferrando M, Melo M, Goyri E, Pellicer A, et al. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010;93(2):447–54. - PubMed
- Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod. 2011;26 (1):245–52. - PubMed
- Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103(2):219–24. - PubMed
- Pinborg A, Gaarslev C, Hougaard C, Andersen AN, Andersen P, Boivin J, et al. Influence of female bodyweight on IVF outcome: a longitudinal multi-centre cohort study of 487 infertile couples. Reprod Biomed Online. 2011;23(4):490–9. - PubMed